Sun Pharmaceutical Industries Limited, India’s largest pharmaceutical company, has announced the re-appointment of Dr. Pawan Goenka as an Independent Director on its Board. This extension, effective from early 2026, ensures that the global pharma giant continues to benefit from the strategic oversight of one of India’s most respected industrial leaders. Dr. Goenka, widely known for his transformative leadership at Mahindra & Mahindra and his current role as Chairperson of IN-SPACe, brings a wealth of experience in R&D, manufacturing, and global scaling to Sun Pharma as it deepens its focus on specialty medicines and complex generics.
Trending
- Congress Leaders to Face Criminal Charges in Rajat Sharma Case
- A New Era of Magic, Josh D’Amaro Appointed Disney CEO
- Anupriya Acharya Makes History as India’s First Jury President for Creative Data Lions
- Pankaj Nihalani Joins Enormous as Head of Creative (Mumbai)
- Sundaram Finance Locks in Rajiv C. Lochan for Second Term as MD
- Bajaj Housing Finance Strengthens Board, Former RBI Executive Director Ajay Kumar Choudhary Joins as Independent Director
- Shree Rama Multi-Tech Appoints Shalin S. Patel as Additional Director
- Dr. Madhu Sharma Joins CGA as Senior Deputy Controller General of Accounts
